Background: Namena Corp. initiated a lawsuit against Ameri-Can Pharma Inc., Thinesh Sivarajah, and 36 Pharma Consulting Services Inc., alleging failure to disclose intellectual property necessary for product development and misappropriation of funds through excessive expense claims.
Parties Involved: Plaintiffs are Namena Corp. and Namena Pharma Corp. Defendants include Ameri-Can Pharma Inc., Thinesh Sivarajah, and 36 Pharma Consulting Services Inc.
Issues/Main Discussion: The motion addressed multiple points, including production of documents from third parties, answering outstanding undertakings and refusals, and the consideration to strike the statement of defense for non-compliance.
Ruling: The court ordered the production of certain documents from third parties and required Sivarajah to reattend discovery to answer specific questions. The motion to strike the defense was denied.
Costs Awarded: The plaintiff was awarded $4,000 in partial indemnity costs, payable by the defendants within 30 days.
